Source: StreetInsider

Press Release: Sekisui Diagnostics : Sekisui Diagnostics Announces Launch of Silaris Influenza A&B Test

Today Sekisui Diagnostics announces the launch of the Silaris™ Influenza A&B Test. The Silaris™ test was developed by Mesa Biotech and utilizes an affordable, polymerase chain reaction (PCR) testing platform specifically for point-of-care (POC) infectious disease diagnosis.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Robert Schruender's photo - President & CEO of Sekisui

President & CEO

Robert Schruender

CEO Approval Rating

87/100

Read more